Myelin oligodendrocyte glycoprotein antibody-associated disease: characterising clinical disease
- PMID: 29992350
- PMCID: PMC6060774
- DOI: 10.1007/s00415-018-8963-z
Myelin oligodendrocyte glycoprotein antibody-associated disease: characterising clinical disease
Erratum in
-
Correction to: Myelin oligodendrocyte glycoprotein antibody-associated disease: characterising clinical disease.J Neurol. 2018 Oct;265(10):2469. doi: 10.1007/s00415-018-9019-0. J Neurol. 2018. PMID: 30151654 Free PMC article.
Comment on
-
Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination.J Neurol Neurosurg Psychiatry. 2018 Feb;89(2):127-137. doi: 10.1136/jnnp-2017-316880. Epub 2017 Nov 15. J Neurol Neurosurg Psychiatry. 2018. PMID: 29142145 Free PMC article.
-
Disease Course and Treatment Responses in Children With Relapsing Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.JAMA Neurol. 2018 Apr 1;75(4):478-487. doi: 10.1001/jamaneurol.2017.4601. JAMA Neurol. 2018. PMID: 29305608 Free PMC article.
-
Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: The MOGADOR study.Neurology. 2018 May 22;90(21):e1858-e1869. doi: 10.1212/WNL.0000000000005560. Epub 2018 Apr 25. Neurology. 2018. PMID: 29695592
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources